Cytokinetics Inc logo

Cytokinetics Inc (CYTK)

$55.96

Cytokinetics Inc (CYTK) Share Price Forecast
Currently 25 wall-street analysts regularly analyze the financials of Cytokinetics Inc on a frequent basis to provide recommendations along with target share price. 25 analysts offering 12-month price forecasts for Cytokinetics Inc (CYTK) have a share price target of $83.56. This median of share price forecast represents a 49.32% upside from the latest price of $55.96 as on 14.11.24.

Cytokinetics Inc (CYTK) Price vs Consensus Price Target

Price
Target Price
As per the chart shown above, analysts believe that the Cytokinetics Inc (CYTK) share price will touch around $83.56 in next 12-months.
Cytokinetics Inc (CYTK) Share Price Forecast v/s Share Price Today
Below is a chart showing the percentage difference between Cytokinetics Inc's share price and its median forecast price. As on 14.11.24, the difference is -37.98%

Cytokinetics Inc (CYTK): Difference between Current Price & Median Forecasted Price

Difference in Percentage terms
Cytokinetics Inc (CYTK) Share Price : Analyst Recommendation
Based on 25 analysts tracking and researching Cytokinetics Inc (CYTK) share have buy recommendation on an average.

3M Ago1M AgoCurrent
Buy
15
15
15
Outperform
6
6
6
Hold
4
4
4
Underperform
0
0
0
Sell
0
0
0
Cytokinetics Inc (CYTK) Share Price Technical Analysis

50 Day Moving Average v/s Current Share Price

Moving Average
Price

200 Day Moving Average v/s Current Share Price

Moving Average
Price

FAQs

The latest share price target for Cytokinetics Inc (CYTK) is $83.56, offered by 25 analysts offering 12-month price forecasts.

Cytokinetics Inc (CYTK) has a maximum of 0.49 upside potential, based on 25 analysts offering 12-month price forecasts.

Based on 25 analysts tracking and researching Cytokinetics Inc (CYTK), 84% have a buy recommendation. Remaining 16% have either sell or hold recommendations.

The latest share price of Cytokinetics Inc (CYTK) is $55.96 as of 14/11/2024.

21 of total 25 analysts offering stock ratings for Cytokinetics Inc CYTK have recommended buy rating.